Quantum computing and biotech companies are testing whether next-generation computing technology could help them develop ...

One could be forgiven for feeling the same way about the current world of drug delivery devices, with an increasingly ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligence ...

Did you know that back in the 1980s and '90s, when South Korea was on the road toward becoming—but had yet to become—the ...

Veeda Group has rebranded to Veeda Lifesciences, reflecting its evolution into a drug development enterprise. It comprises four strategic units: Clinical Trials, Healthy Volunteer Services, Biopharma ...

Centessa Pharmaceuticals, founded from the merger of 10 biotech companies, is based on an asset-centric model, primarily ...

Ebselen is under clinical development by Sound Pharmaceuticals and currently in Phase II for Drug Toxicity. According to GlobalData, Phase II drugs for Drug Toxicity have a 65% phase transition ...

Traws Pharma (TRAW) announced progress in the development of its investigational ... We evaluated the effects of drug treatment in mice exposed to human H5N1, where the virus was isolated from ...

TAS-0728 is under development for the treatment of solid tumors such as urothelial cancer, biliary tract cancer, breast cancer, non-small cell lung cancer, colorectal cancer, gastroesophageal junction ...